In Vivo Studies of Mutant Fibrillin-1 Microfibrils
Open Access
- 1 August 2010
- journal article
- Published by Elsevier BV
- Vol. 285 (32), 24943-24955
- https://doi.org/10.1074/jbc.m110.130021
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Microfibril Structure Masks Fibrillin-2 in Postnatal TissuesPublished by Elsevier BV ,2010
- Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin SyndromeScience Translational Medicine, 2010
- Latent Transforming Growth Factor β-binding Proteins and Fibulins Compete for Fibrillin-1 and Exhibit Exquisite Specificities in Binding SitesPublished by Elsevier BV ,2009
- Targeting of Bone Morphogenetic Protein Growth Factor Complexes to FibrillinPublished by Elsevier BV ,2008
- Effect of Mutation Type and Location on Clinical Outcome in 1,013 Probands with Marfan Syndrome or Related Phenotypes and FBN1 Mutations: An International StudyAmerican Journal of Human Genetics, 2007
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Fibrillin-1: Organization in Microfibrils and Structural PropertiesJournal of Molecular Biology, 1996
- Delineation of the Marfan phenotype associated with mutations in exons 23–32 of theFBN1 geneAmerican Journal of Medical Genetics, 1996
- Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype.JCI Insight, 1995